ASO Visual Abstract: Larger Tumor Size and Elevated Serum Chromogranin A Levels Predict Metastatic Disease on DOTATATE Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors

被引：0
|
作者：
Labora, Amanda [1 ]
Shimizu, Takayuki [1 ]
Moore, Alexandra [1 ]
Premji, Alykhan [1 ]
Armstrong, Wesley R. [2 ]
Chen, Kevin Y. [2 ]
Link, Jason [1 ]
Chan, Charlotte S. [1 ]
Allen-Aurbach, Martin S. [3 ]
Donahue, Timothy R. [1 ]
机构：
[1] Univ Calif Los Angeles, Dept Surg, Los Angeles, CA 90033 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA USA
[3] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Ahmanson Translat Theranost Div, Los Angeles, CA USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2025年 / 32卷 / 02期
关键词：
D O I：
10.1245/s10434-024-15740-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1197 / 1198
页数：2
相关论文
共 18 条
  • [1] Larger Tumor Size and Elevated Serum Chromogranin A Levels Predict Metastatic Disease on DOTATATE Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors
    Labora, Amanda
    Shimizu, Takayuki
    Moore, Alexandra
    Premji, Alykhan
    Armstrong, Wesley R.
    Chen, Kevin Y.
    Link, Jason
    Chan, Charlotte S.
    Allen-Auerbach, Martin S.
    Donahue, Timothy R.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (10) : 6875 - 6882
  • [2] Plasma Chromogranin A Levels Predict Survival and Tumor Response in Patients with Advanced Gastroenteropancreatic Neuroendocrine Tumors
    Chou, Wen-Chi
    Chen, Jen-Shi
    Hung, Yu-Shin
    Hsu, Jun-Te
    Chen, Tse-Ching
    Sun, Chien-Feng
    Lu, Chang-Hsien
    Hwang, Tsann-Long
    ANTICANCER RESEARCH, 2014, 34 (10) : 5661 - 5669
  • [3] Chromogranin A (CgA) serum levels correlate with hepatic tumor burden in patients with neuroendocrine gastroenteropancreatic (GEP) tumors
    Rinke, A
    Wilke, A
    Mayer, C
    Scherag, A
    Klose, KJ
    Arnold, R
    NEUROENDOCRINOLOGY, 2006, 83 (01) : 45 - 45
  • [4] Extrahepatic 68Ga-DOTATATE-Avid Tumor Volume and serum Chromogranin A Predict Short-Term Outcome of 177Lu-DOTATATE in Late-Stage Metastatic Gastroenteropancreatic Neuroendocrine Tumors
    Song, Hong
    Kunz, Pamela
    Franc, Benjamin
    Moradi, Farshad
    Fisher, George
    Aparici, Carina Mari
    Iagaru, Andrei
    Davidzon, Guido
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [5] Extrahepatic 68Ga-DOTATATE-Avid Tumor Volume and Serum Chromogranin A Predict Short-Term Outcome of 177Lu-DOTATATE in Late-Stage Metastatic Gastroenteropancreatic Neuroendocrine Tumors
    Song, H.
    Kunz, P.
    Franc, B.
    Moradi, F.
    Fisher, G.
    Aparici, Mari C.
    Lagaru, A.
    Davidzon, G.
    NEUROENDOCRINOLOGY, 2020, 110 : 274 - 274
  • [6] ASO Visual Abstract: Diagnostic Immunostaining and Tumor Markers Predict Prognosis of Patients with Esophageal Neuroendocrine Carcinoma
    Makoto Sohda
    Hiroshi Saeki
    Hiroyuki Kuwano
    Tatsuya Miyazaki
    Takehiko Yokobori
    Akihiko Sano
    Makoto Sakai
    Yoshihiro Kakeji
    Yasushi Toh
    Yuichiro Doki
    Hisahiro Matsubara
    Annals of Surgical Oncology, 2021, 28 : 444 - 445
  • [7] ASO Visual Abstract: Diagnostic Immunostaining and Tumor Markers Predict Prognosis of Patients with Esophageal Neuroendocrine Carcinoma
    Sohda, Makoto
    Saeki, Hiroshi
    Kuwano, Hiroyuki
    Miyazaki, Tatsuya
    Yokobori, Takehiko
    Sano, Akihiko
    Sakai, Makoto
    Kakeji, Yoshihiro
    Toh, Yasushi
    Doki, Yuichiro
    Matsubara, Hisahiro
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 3) : 444 - 445
  • [8] ASO Visual Abstract: Peptide Receptor Radionuclide Therapy Improves Survival in Patients Who Progress After Resection of Gastroenteropancreatic Neuroendocrine Tumors
    Borbon, Luis C.
    Sherman, Scott K.
    Breheny, Patrick J.
    Chandrasekharan, Chandrikha
    Menda, Yusuf
    Bushnell, David
    Bellizzi, Andrew M.
    Ear, Po H.
    O'Dorisio, M. Sue
    O'Dorisio, Thomas M.
    Dillon, Joseph S.
    Howe, James R.
    ANNALS OF SURGICAL ONCOLOGY, 2025, 32 (02) : 1193 - 1194
  • [9] Increased Tumor Size and Progression Free Survival after 177Lu-DOTATATE for Metastatic Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETS)
    Patel, J.
    Zhang, K.
    Gbolahan, O. B.
    Schuster, D. M.
    Muzahir, S.
    Patel, P. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E477 - E478
  • [10] Elevated serum bioactive ghrelin levels in patients with metastatic neuroendocrine tumors maintains body weight
    Wang, HS
    Oh, DS
    Ohning, GV
    Pisegna, JR
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S78 - S78
12